Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Intraperitoneal (IP) Therapy With Cisplatin or Carboplatin and Floxuridine (FUdR) as Consolidation for Ovarian and Gastrointestinal Malignancies

NCT00005049 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT00005049
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005049 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Intraperitoneal (IP) Therapy With Cisplatin or Carboplatin and Floxuridine (FUdR) as Consolidation for Ovarian and Gastrointestinal Malignancies
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Completed
Start date
May 31, 1997
Completion date
Not reported
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, gastric cancer, gastrointestinal carcinoid tumor, gastrointestinal stromal tumor, ovarian cancer, peritoneal cavity cancer, small intestine cancer